Jeffrey Sklar, Director at Alliqua BioMedical, Inc. (ALQA), bought 1,500 shares at $2.95 ($4K) on 2015-11-06, disclosed to the SEC on 2015-11-12.
Open-market purchase of $4k ALQA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.